Indication

Malignant esophageal obstruction

Malignant esophageal obstruction refers to the pathological narrowing or complete blockage of the esophageal lumen caused by neoplastic proliferation. Read more about Malignant esophageal obstruction

1 drugs 1 manufacturers

Drugs that treat it

Common Malignant esophageal obstruction therapies.

Showing 1–1 of 1 drugs

Sort

PHOTOFRIN (porfimer sodium)

ANTINEOPLASTIC - PHOTOSENSITIZERS·NON-SMALL CELL LUNG CANCER·+2

PINNACLE BIOLOG

Filter & compare in the drug finder →Opens the drug finder with Malignant esophageal obstruction preselected.

News & literature

Coming soon

Related codes

Coming soon

About Malignant esophageal obstruction.

Malignant esophageal obstruction refers to the pathological narrowing or complete blockage of the esophageal lumen caused by neoplastic proliferation.

It primarily affects adults with advanced or unresectable gastrointestinal and thoracic malignancies, most commonly intrinsic squamous cell carcinoma or adenocarcinoma of the esophagus, as well as extrinsic compression from adjacent lung, mediastinal, or metastatic tumors.

The condition is pathologically driven by transmural tumor infiltration, exophytic intraluminal mass growth, or malignant stricture formation.

Clinically, it presents with progressive dysphagia—initially for solids and advancing to liquids—leading to profound weight loss, severe malnutrition, regurgitation, and a heightened risk of tracheoesophageal fistula formation or aspiration pneumonia.

nih.gov
Malignant esophageal obstruction refers to the pathological narrowing or complete blockage of the esophageal lumen caused by neoplastic proliferation It primarily affects adults with advanced or unresectable gastrointestinal and thoracic malignancies, most commonly intrinsic squamous cell carcinoma or adenocarcinoma of the esophagus, as well as extrinsic compression from adjacent lung, mediastinal, or metastatic tumors Clinically, it presents with progressive dysphagia—initially for solids and a...
nih.gov
Malignant esophageal obstruction refers to the pathological narrowing or complete blockage of the esophageal lumen caused by neoplastic proliferation It primarily affects adults with advanced or unresectable gastrointestinal and thoracic malignancies, most commonly intrinsic squamous cell carcinoma or adenocarcinoma of the esophagus, as well as extrinsic compression from adjacent lung, mediastinal, or metastatic tumors The condition is pathologically driven by transmural tumor infiltration, exop...
cancer.gov
It primarily affects adults with advanced or unresectable gastrointestinal and thoracic malignancies, most commonly intrinsic squamous cell carcinoma or adenocarcinoma of the esophagus, as well as extrinsic compression from adjacent lung, mediastinal, or metastatic tumors The condition is pathologically driven by transmural tumor infiltration, exophytic intraluminal mass growth, or malignant stricture formation
nih.gov
Clinically, it presents with progressive dysphagia—initially for solids and advancing to liquids—leading to profound weight loss, severe malnutrition, regurgitation, and a heightened risk of tracheoesophageal fistula formation or aspiration pneumonia
nih.gov
Clinically, it presents with progressive dysphagia—initially for solids and advancing to liquids—leading to profound weight loss, severe malnutrition, regurgitation, and a heightened risk of tracheoesophageal fistula formation or aspiration pneumonia
nih.gov
Clinically, it presents with progressive dysphagia—initially for solids and advancing to liquids—leading to profound weight loss, severe malnutrition, regurgitation, and a heightened risk of tracheoesophageal fistula formation or aspiration pneumonia

Personalize your experience

Follow Malignant esophageal obstruction and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it